Get started
Author

Marianna Lo Re

Observed names: LO RE, Marianna, Lo Re Marianna, Re, Marianna Lo
OpenAlex ID: A5113988894
COVID-19 Severity in Multiple Sclerosis
2021 · Maria Pia Sormani, Irene Schiavetti, et al. · Neurology Neuroimmunology & Neuroinflammation · 70
PDF
Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: a cohort study
2017 · Paolo Ragonese, Paolo Aridon, et al. · BMC Neurology · 56
PDF
Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers
2015 · Marianna Lo Re, Marco Capobianco, et al. · Neurology and Therapy · 49
PDF
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study
2021 · Maria Pia Sormani, Irene Schiavetti, et al. · Multiple Sclerosis Journal · 46
High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study
2016 · Simona Malucchi, Marco Capobianco, et al. · Neurology and Therapy · 29
PDF
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study
2021 · Sebastiano Bucello, Pietro Annovazzi, et al. · Journal of Neurology · 21
Benign SARS-CoV-2 infection in MOG-antibodies associated disorder during tocilizumab treatment
2020 · Fabio Giuseppe Masuccio, Marianna Lo Re, et al. · Multiple Sclerosis and Related Disorders · 13
PDF
ECTRIMS 2013: Posters I
2013 · MAZZOLA, Maria Antonietta, RAGONESE, Paolo, et al. · Multiple Sclerosis Journal · 12
PDF
In multiple sclerosis patients a single serum neurofilament light chain (sNFL) dosage is strongly associated with 12 months outcome: data from a real-life clinical setting
2024 · Simona Malucchi, Cecilia Irene Bava, et al. · Journal of Neurology · 10
PDF
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study
2022 · Marta Ponzano, Irene Schiavetti, et al. · Multiple Sclerosis and Related Disorders · 10
PDF
Acute confusional state in HaNDL syndrome (transient headache and neurologic deficits with cerebrospinal fluid lymphocytosis)
2014 · Marianna Lo Re, Alessia di Sapio, et al. · Neurological Sciences · 9
Reversible posterior leukoencephalopathy syndrome in a patient with thrombotic thrombocytopenic purpura
2011 · Paolo Aridon, Paolo Ragonese, et al. · Neurological Sciences · 8
Rituximab suppresses disease activity after natalizumab withdrawal: an exploratory study
2016 · Simona Malucchi, Marco Capobianco, et al. · Multiple Sclerosis and Demyelinating Disorders · 3
PDF
Successful pregnancy and disease outcomes in a NMOSD patient treated with tocilizumab
2021 · Marco Capobianco, Luca Marozio, et al. · Neuroimmunology Reports · 1
PDF
Correction: In multiple sclerosis patients a single serum neurofilament light chain (sNFL) dosage is strongly associated with 12 months outcome: data from a real-life clinical setting
2025 · Simona Malucchi, Cecilia Irene Bava, et al. · Journal of Neurology
PDF
Profile of serum biomarkers in seronegative NMOSD (S50.009)
2023 · Sara Carta, Alessadro Dinoto, et al. · Neurology
Clinical Characteristics of MOG and AQP associated Neuromyelitis Optica Spectrum Disorder (NMOSD) in Adults (S13.002)
2018 · Marco Alfonso Capobianco, Arianna Sala, et al. · Neurology
High risk PML patients switching from natalizumab to alemtuzumab (P2.407)
2017 · Antonio Bertolotto, Marco Capobianco, et al. · Neurology
A Low Percentage of CD4+ Cells Can Predict Disease Reactivation after Natalizumab Discontinuation (P2.063)
2016 · Antonio Bertolotto, Marianna Lo Re, et al. · Neurology
Early Cyclophosphamide Pulses Therapy is able to Reduce Disease Reactivation after Natalizumab Discontinuation: Preliminary Results from a Multicentric Database. (P3.292)
2015 · Marco Capobianco, Marianna Lo Re, et al. · Neurology
Extracellular Vesicles Isolated By Cerebrospinal Fluid As Biomarkers Of Inflammation In Multiple Sclerosis And Inflammatory Neurological Diseases (P4.127)
2014 · Paolo Ragonese, Maria Antonietta Mazzola, et al. · Neurology
Clinical and Instrumental Findings and Disability Progression in Primary Progressive and Progressive Relapsing Multiple Sclerosis: A Comparison Study of a Sicilian Group of Patients (P04.139)
2013 · Giuseppe Salemi, Paolo Ragonese, et al. · Neurology
Clinical and instrumental predictors of efficacy of natalizumab therapy in the course of multiple sclerosis: a retrospective study from a single centre
2013 · LO RE, Vincenzina, SALEMI, Giuseppe, et al. · Nova Science Publishers (Nova Science Publishers, Inc.)
Works count: 25
Citation count: 338
H-index: 10
I10-index: 10
Year
Topic
Type